A new study reveals a purified medical THC/CBD oil formulation drastically reduces severe agitation in late-stage dementia.
In the phase 2 LiBBY trial presented, tetrahydrocannabinol and cannabidiol reduced agitation scores and improved clinician-rated outcomes in patients with advanced dementia.
A combination of THC and CBD eased symptoms in an especially frail population: patients with advanced dementia near the end ...
6don MSN
Cannabis-derived treatment eases agitation in hospice-eligible dementia patients, trial finds
In a first-of-its-kind clinical trial, U.S. researchers found that people with agitation and dementia in late life who took a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results